New England Peptide to expand in Gardner

Worcester Business Journal Online

February 24, 2015

By: Sam Bonacci

Biomedical firm New England Peptide (NEP) will expand its Gardner facility to create additional research and production space, the company announced Tuesday.

The company, in business since 1998, will expand its facilities by 12,500 square feet. The new space will allow NEP to "substantially" reduce its production time of peptides, a piece of protein used in the biomedical research industry by such organizations as Pfizer and the Dana Farber Cancer Institute.

The company also announced that it intends to employ an additional three to five people a year over the next five years. The company currently employs approximately 43.

The loan for the expansion was financed through Fitchburg-based Rollstone Bank & Trust.

Testimonials

"THANKS AGAIN for all the intellectual support that NEP has provided to us over the last year. My colleagues have been overwhelmingly impressed with the quality of service and level of thought that you have put into researching and thinking about our particular peptide and antibody production needs. The level of scholarship went well beyond what we expected from any peptide and antibody company, and was crucial in shaping our decisions. It has truly been a pleasure corresponding with you."
Cliff N. PhD - Lawrence Berkeley National Laboratory